Comparison Overview

Sanofi

VS

AbbVie

Sanofi

46 Avenue de la Grande-Armée, Paris, France, 75017, FR
Last Update: 2025-12-09
View Profile
Between 800 and 849
http://www.sanofi.com

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 88,229
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

AbbVie

1 Waukegan Road, None, North Chicago, Illinois, US, 60064
Last Update: 2025-12-11
Between 800 and 849
http://www.abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 58,020
Subsidiaries: 15
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/abbvie.jpeg
AbbVie
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Sanofi
100%
Compliance Rate
0/4 Standards Verified
AbbVie
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Sanofi in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for AbbVie in 2025.

Incident History — Sanofi (X = Date, Y = Severity)

Sanofi cyber incidents detection timeline including parent company and subsidiaries

Incident History — AbbVie (X = Date, Y = Severity)

AbbVie cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sanofi.jpeg
Sanofi
Incidents

No Incident

https://images.rankiteo.com/companyimages/abbvie.jpeg
AbbVie
Incidents

Date Detected: 6/2023
Type:Breach
Attack Vector: Exploitation of Vulnerability
Motivation: Financial gain
Blog: Blog

FAQ

Both Sanofi company and AbbVie company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

AbbVie company has historically faced a number of disclosed cyber incidents, whereas Sanofi company has not reported any.

In the current year, AbbVie company and Sanofi company have not reported any cyber incidents.

Neither AbbVie company nor Sanofi company has reported experiencing a ransomware attack publicly.

AbbVie company has disclosed at least one data breach, while Sanofi company has not reported such incidents publicly.

Neither AbbVie company nor Sanofi company has reported experiencing targeted cyberattacks publicly.

Neither Sanofi company nor AbbVie company has reported experiencing or disclosing vulnerabilities publicly.

Neither Sanofi nor AbbVie holds any compliance certifications.

Neither company holds any compliance certifications.

AbbVie company has more subsidiaries worldwide compared to Sanofi company.

Sanofi company employs more people globally than AbbVie company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Sanofi nor AbbVie holds SOC 2 Type 1 certification.

Neither Sanofi nor AbbVie holds SOC 2 Type 2 certification.

Neither Sanofi nor AbbVie holds ISO 27001 certification.

Neither Sanofi nor AbbVie holds PCI DSS certification.

Neither Sanofi nor AbbVie holds HIPAA certification.

Neither Sanofi nor AbbVie holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References
Description

MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.

Published
Date
2025-12-11
Updated
Date
2025-12-11
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References